Postnatal expression of cytochrome P450 1A1, 2A3, and 2B1 mRNA in neonatal rat lung: Influence of maternal nicotine exposure

Experimental Lung Research

Volumn 30, Issue 2, 2004, Pages 121-133

  Gamieldien, Kareemah ^a   Maritz, Gert S ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

CYP1A1 mRNA; CYP2A3 mRNA; CYP2B1 mRNA; Lung development; Nicotine

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2A3; CYTOCHROME P450 2B1; MESSENGER RNA; NICOTINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS LUNG; LACTATION; LUNG PARENCHYMA; LUNG TOXICITY; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RAT; WEANING;

EID: 1442311063     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490266484     Document Type: Article

References (48)

1. Hukkanen J, Pelkonen O, Raunio H: Expression of xenobiotic metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD. Eur Respir J. 2001;18(Suppl 32):122s-126s.
2. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 1996;6:1-42.
3. Raunio H, Hakkola J, Hukkanen J, Lassila A, Päivärinta K, Pelkonen O, Anttila S, Piipari R, Boobis AR, Edwards RJ: Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. Exp Toxicol Pathol. 1999;51:412-417.
4. Lee CZ, Royce FH, Denison MS, Pinkerton KE: Effect of in utero and postnatal exposure to environmental tobacco smoke on the developmental expression of pulmonary cytochrome P450 monooxygenases. J Biochem Mol Toxicol. 2000;14:121-130.
5. Luck W, Nau H: Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br Clin Pharmacol 1984;18:1-15.
6. Van Gilder TJ, Remington PL, Maelioo MCF: The direct effects of nicotine use in the human health. Wisconsin Med J. 1997;96:43-48.
7. Lambers DS, Clark KE: The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996;20:115-126.
8. Maritz GS, Woolward KM: Effect of maternal nicotine exposure on neonatal lung elastic tissue and possible consequences. South Afr Med J. 1992;81:5117-5119.
9. Maritz GS: Pre-and postnatal carbohydrate metabolism of rat lung tissue. The effect of maternal nicotine exposure. Arch Toxicol. 1986;59:89-93.
10. Maritz GS: Maternal nicotine exposure and carbohydrate metabolism of fetal and neonatal lung tissue: response to nicotine withdrawal. Respiration. 1987;51:232-240.
11. Maritz GS, Dennis H: Maternal nicotine exposure during gestation and lactation interferes with alveolar development in the neonatal lung. Reprod Fertil Dev. 1998;10:255-262.
12. Murphy SE, Isaac IS, Ding X, McIntee EJ: Specificity of cytochrome P450 2A3-catalyzed alpha-hydroxylation of N-nitrosonornicotine enantiomers. Drug Metab Dispos. 2000;28:1263-1268.
13. Messina ES, Tyndale RF, Sellus EM: A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther. 1997;282:1608-1614.
14. Myksis S, Hoffmann E, Tyndale RE: Regional and cellular induction of nicotine metabolizing CYP 2B1 in rat brain by chronic nicotine treatment. Biochem Pharmacol. 2000;59:1501-1511.
15. Le Gal A, Dréano Y, Lucas D, Bertthou F: Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosoethylamine and N-mtrosobenzylethylamine. Toxicol Lett. 2003;144:77-91.
16. Nakayama H, Okuda H, Nakashima T, Imaoka S, Funae Y: Nicotine metabolism by rat hepatic cytochrome P450s. Biochem Pharmacol. 1993;45:2554-2556.
17. Iba MM, Scholl H, FungJ, Thomas PE, Alam J: Induction of pulmonary CYP1A1 by nicotine. Xenobiotica. 1998;28:827-843.
18. Wei C, Caccavale RJ, Weyand EH: Induction of CYP1A1 and CYP1A2 expressions by prototypical inducers in the human lung. Cancer Lett. 2002;178:25-36.
19. Schoedel KA, Sellers EM, Palmour R, Tyndale RF: Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African Green Monkeys after long-term nicotine administration. MoI Pharmacol. 2003;63:96-104.
20. Dempsey D, Jacob P, III Benowitz N: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301:594-598.
21. Sekhon H, Keller JA, Benowitz N, Spindel ER: Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. AmJ Respir Crit Care Med. 2001;164:989-994.
22. Szüts T, Olson S, Lindquist NG, Ullberg S, Pilotti A, Enzell C: Long-term fate of 14C-nicotine in the mouse: retention in the bronchi, melanin-containing tissues, and urinary bladder wall. Toxicology. 1978;10:207-220.
23. Benowitz NL, Jacob P: Nicotine and carbon monoxide intake from high and low-yield cigarettes. Clin Pharmac Ther. 1984;36:265-269.
24. Gleason MN, Gosselin RE, Hodge HC: Clinical Toxicology of Commercial Products, 2nd ed. Baltimore: Williams and Williams; 1963:115.
25. Luck W, Nau H: Nicotine and cotinine concentrations in serum and milk of nursing mothers. Br Clin Pharmacol. 1984;18:1-15.
26. Stephans MB, Wilkerson N: Physiologic effects of maternal smoking on breast-feeding infants. J Am Acad Nurse Pract. 5:105-113.
27. Dahlstrom A, Lundell B, Curvall M, Thapper L: Nicotine and cotinine concentrations in the nursing mother and her infant. Acta Paediatr Scand. 1990;79:142.
28. Czekaj P, Wiaderkiewicz A, Florek E, Wiaderkiewicz R: Expression of cytochrome CYP2B1/2 in nonpregnant, pregnant and fetal rats exposed to tobacco smoke. Acta Biochim Pol. 2000;47:1115-1127.
29. Gerde P, Muggenburg BA, Scott GG, Lewis JL, Pyon KH, Dahl AR: Local metabolism in lung airways increases the uncertainty of pyrene as a biomarker of the polycyclic aromatic hydrocarbon exposure. Carcinogenesis. 1998;19:493-500.
30. Russell MAH, Feyerabend C: Cigarette smoking: dependence on high-nicotine boli. Drug Metab Rev. 1978;8:29-57.
31. Kikkawa Y: Diverse role of pulmonary cytochrome P-450 monoxygenase. Lab Invest. 1992;67:535-539.
32. Miyamoto M, Umetsu Y, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Nemoto N, Sato K, Ariyoshi N, Kamataki T: CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem Biophys Res. Commun. 1999;261:658-660.
33. Massaro D, Massaro GD: Pre-and postnatal development, maturation, and plasticity. Invited review: Pulmonary alveoli: formation, the "call for oxygen", and other regulators. Am J Physiol. 2002;282:L345-L358.
34. Iba MM, Pak YW, Thomas PE, Fisher H, Sekowski A, Halladay AK, Wagner GC: Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P450 (CYP) 1 A expression by nicotine feeding. Drug Metab Dispos. 1999;2:977-982.
35. Yamazaki H, Inoue K, Hashimoto M, Shimada T: Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol. 1999;73:65-70.
36. Yang X, Borg LA, Siman CM, Erikson UJ: Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos. Anat Rec. 1998;251:303-315.
37. Maritz GS, Thomas R-A: The influence of maternal nicotine exposure on the interalveolar septal status of neonatal rat lung. Cell Biol Int. 1994;18:747-757.
38. Hecht SS, Hochalter JB, Villalta PW, Murphy SE: 2′-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Proc Natl Acad Sci U S A. 2000;97:12493-12497.
39. Hecht S, Hoffman D: Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 1990;9:875-884.
40. Hellmold H, Magnusson M, Pelto-Huikko M, Rylander T, Gustafsson J-A, Warner M: Identification of CYP2A3 as a major cytochrome P450 enzyme in the female prepubertal rat breast. Mol Pharmacol. 1998;53:475-482.
41. Sekhon HS, Keller JA, Proskocil BJ, Martin EL, Spindel ER: Maternal nicotine exposure upregulates gene expression in fetal monkey lung. Association with alpha 7-nicotinic acetylcholine receptors. Am J Respir Cell Mol Biol. 2002;26:31-41.
42. Riah O, Dousset JC, Courriere P, Stigliani JL, Baziard-Mouyset G, Belahsen Y: Evidence that nicotine acethylcholine receptors are not the main targets of nicotine toxicity. Toxicol Lett. 1999;109:21-29.
43. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y: Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther. 1996;277:1010-1015.
44. Schroff KC, Lovioh P, Schmitz O, Aschoff S, Richter E, Rennen J: Effects of cotinine at cholinergic nicotinic receptors of the sympathetic superior cervical ganglion of the mouse. Toxicology. 2000;144:99-105.
45. Plummer HK III, Sheppard BJ, Schuller H: Interaction of tobacco-specific toxicants with nicotinic cholinergic regulation of fetal pulmonary neuroendocrine cells: implications for pediatric lung disease. Exp lung Res. 2000;26:121-135.
46. Benowitz NL, Jacob P III: Metabolism of nicotine and cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994;56:483-493.
47. Heusch WL, Maneckjee R: Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis 1998;19:551-556.
48. Wright SC, Zhong J, Zheng H: Nicotine inhibition of apoptosis suggests a role in tumour promotion. FASEB J. 1993;7:1045-1051.